Genomic landscape in acute myeloid leukemia and its implications in risk classification and targeted therapies

Acute myeloid leukemia (AML) is a heterogeneous hematologic malignancy in terms of clinical features, underlying pathogenesis and treatment outcomes. Recent advances in genomic techniques have unraveled the molecular complexity of AML leukemogenesis, which in turn have led to refinement of risk stra...

Descripción completa

Detalles Bibliográficos
Autores principales: Hou, Hsin-An, Tien, Hwei-Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7372828/
https://www.ncbi.nlm.nih.gov/pubmed/32690020
http://dx.doi.org/10.1186/s12929-020-00674-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7372828/
https://www.ncbi.nlm.nih.gov/pubmed/32690020
http://dx.doi.org/10.1186/s12929-020-00674-7

Ejemplares similares